Advances in new targets for immunotherapy of small cell lung cancer

Advances in new targets for immunotherapy of small cell lung cancer

Abstract Small cell lung cancer (SCLC) is one of the highly aggressive malignancies characterized by rapid growth and early metastasis, but treatment options are limited. For SCLC, carboplatin or cisplatin in combination with etoposide chemotherapy has been considered the only standard of care, but...

Full description

Bibliographic Details
Main Authors: Zitong Zheng, Juanjuan Liu, Junling Ma, Runting Kang, Zhen Liu, Jiangyong Yu
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Thoracic Cancer
Subjects:
DLL3
immunotherapy
LAG‐3
small cell lung cancer
TIGIT
Online Access:https://doi.org/10.1111/1759-7714.15178

Similar Items

Similar Items